Companies: 10,795·Total market cap: $144.5T
POINT Biopharma Global Inc.

POINT Biopharma Global Inc.

PNTNASDAQHealthcare
$12.50
+$0.02(+0.16%)
Market Cap$1.3B
P/E Ratio
52W High$14.35
52W Low$6.57
Overview

POINT Biopharma Global Inc. (PNT) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · PNT · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-12
Revenue
Revenue$0.23B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.23B$0.00B$0.00B$0.00B
Gross Margin %(computed)100.00%
Operating Expenses
R&D Expenses$0.08B$0.03B$0.01B$0.00B
G&A Expenses$0.02B$0.01B$0.00B$0.00B
Total Operating Expenses$0.10B$0.05B$0.01B$0.00B
Operating Income$0.13B($0.05B)($0.01B)($0.00B)
Operating Margin %(computed)55.40%
Interest Income$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B
Income Before Tax$0.13B($0.05B)($0.01B)($0.00B)
Income Tax Expense$0.03B$0.00B$0.00B$0.00B
Net Income$0.10B($0.05B)($0.01B)($0.00B)
Net Margin %(computed)43.38%
Per Share & EBITDA
EPS (Basic)$1.04$-0.62$-0.34$0.00
Wtd Avg Shares0.09B0.07B0.04B0.00B
EBITDA$0.13B($0.05B)($0.01B)($0.00B)
EBITDA Margin %(computed)56.19%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B

Explore more POINT Biopharma Global Inc. data

About POINT Biopharma Global Inc. (PNT) Income Statement

POINT Biopharma Global Inc. (PNT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, PNT reported revenue of $0.23B, gross profit of $0.23B (gross margin 100.00%), and net income of $0.10B — a net profit margin of 43.38%.

Frequently asked questions

PNT · 4 questions

POINT Biopharma Global Inc. (PNT) reported revenue of $0.23B for 2022, up —% year-over-year.

PNT revenuePNT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09